Presumptive Treatment and Medical Screening for Parasites in Refugees Resettling to the United States Authors
Tropical, Travel and Emerging Infections (L Chen, Section Editor)
First Online: 18 May 2013 DOI:
Cite this article as: Stauffer, W.M., Cantey, P.T., Montgomery, S. et al. Curr Infect Dis Rep (2013) 15: 222. doi:10.1007/s11908-013-0331-7 Abstract
More than 50,000 refugees are resettled to the United States annually, many from areas highly endemic for parasites. Some of these infections present little clinical consequence after migration, but others are responsible for morbidity and mortality. The Centers for Disease Control and Prevention has issued predeparture presumptive treatment and postarrival medical guidelines for the management of parasites. Although these guidelines are evidence based, there remain significant challenges to presumptive treatment programs in refugees. Gaps in the evidence continue; resettling populations are continually changing, thus altering the epidemiology; and there are logistical and cost barriers to fully implementing recommendations. This article will review the evolution and status of current guidelines, as well as identify gaps and challenges to full implementation. It is imperative for clinicians serving this population to be familiar with interventions received by refugees, since previous treatment will impact screening, diagnostic evaluation, and treatment decisions.
Keywords Intestinal parasites Schistosomiasis Refugees Presumptive therapy Screening Strongyloidiasis References
United Nations High Commissioner for Refugees. Global Trends in 2012. 60 years and still counting. [Accessed May 21, 2012]. Available from
United States Department of State, 2012. Proposed refugee admission guidelines for fiscal year 2012; report to Congress. [Accessed May 21, 2012] Available from
de Silva NR, Booker S, Hotez PJ, et al. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol. 2003;19:547–51.
Bethony J, Brooker S, Albonico M, et al. Soil-transmitted helminth infections: Ascaris, trichuriasis, and hookworm. Lancet. 2006;367:1521–32.
Hotez PJ, Molyneux DH, Fenwick A, et al. Control of neglected tropical diseases. N Engl J Med. 2007;357:1018–27.
Peterson MH, Konczyk MR, Ambrosino K, et al. Parasitic screening of a refugee population in Illinois. Diagn Microbiol Infect Dis. 2001;40(1):75–6.
Mody RK. Intestinal parasites. In: Walker PF, Barnett ED, editors. Immigrant medicine, vol. 1. 1st ed. Philadelphia: Elsevier; 2007.
Lurio J, Verson H, Karp S. Intestinal Parasites in Cambodians: comparison of diagnostic methods used in screening refugees with implications for treatment of populations with high rates of infestation. J Am Board Fam Pract. 1991;4:71–8.
Miller JM, Boyd HA, Ostrowski SR, et al. Malaria, intestinal parasites, and schistosomiasis among Barawan Somali refugees resettling to the U.S.: A strategy to reduce morbidity and decrease the risk of imported infections. Am J Trop Med Hyg. 2000;62:115–21.
Muennig P, Pallin D, Sell RL, Chan MS. The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants. N Engl J Med. 1999;340:773–9.
Swanson SJ, Phares CR, Mamo B, et al. Albendazole therapy and enteric parasites in United States-bound refugees. N Engl J Med. 2012;366:1498–507.
Geltman PL, Cochran J, Hedgecock C. Intestinal parasites among African refugees resettled in Massachusetts and the impact of an overseas predeparture treatment program. Am J Trop Med Hyg. 2003;69:657–62.
Posey DL, Blackburn BG, Weinberg M, et al. High prevalence and presumptive treatment of schistosomiasis and strongyloides among African refugees. Clin Infect Dis. 2007;45(10):1210–5.
Caruana SR, Kelly HA, Ngeow JY, et al. Undiagnosed and potentially lethal parasite infections among immigrants and refugees in Australia. J Trav Med. 2006;13:233–9.
Boulware DR, Stauffer WM, Hendel-Paterson BR, Rocha J, et al. Maltreatment of
Strongyloides infection: case series and worldwide physician–in-training survey. Am J Med. 2007;120(60):545;e1-8.
de Silva S, Saykao P, Kelly H, et al. Chronic
infection in Laotian immigrants and refugees 7–20 years after resettlement in Australia. Epidemiol Infect. 2002;128(3):439–44.
Lim S, Katz K, Krajden S, et al. Complicated and fatal
infection in Canadians: risk factors, diagnosis and management. CMAJ. 2004;171:479–84.
Newberry AM, Williams DN, Stauffer WM, et al.
hyperinfection presenting as acute respiratory failure and gram-negative sepsis. Chest. 2005;128(5):3681–4.
Gill GV, Beeching NJ, Khoo S, et al. A British Second World War veteran with disseminated strongyloides. Trans Roy Soc Trop Med Hyg. 2004;98:382–6.
Orem J, Mayanja B, Okongo M, Morgan D.
hyperinfection in a patient with AIDS in Uganda successfully treated with ivermectin. Clin Infect Dis. 2003;37(1):152–3.
Ross AGP, Bartley PB, Sleigh AC, et al. Schistosomiasis. N Engl J Med. 2002;346(16):1212–20.
Aryeetey ME, Wagnatsuma Y, Yegoah G, et al. Urinary schistosomiasis in southern Ghana: 1. prevalence and morbidity assessment in three (defined) rural areas drained by the Densu River. Parasitol Int. 2000;49(2):155–63.
Seybolt LM, Christiansen D, Barnett ED. Diagnostic evaluation of newly arrived asymptomatic refugees with eosinophilia. Clin Infect Dis. 2006;42(3):363–7.
Summer AP, Stauffer W, Maroushek SR, Nevins TE. Hematuria in children due to schistosomiasis in a non-endemic setting. Clin Pediatr. 2006;45(2):177–81.
Rotger M, Serra T, de Cardenas MG, et al. Increasing incidence of imported schistosomiasis in Mallorca, Spain. Eur J Clin Microbiol Infect Dis. 2004;13(11):855–6.
Kameh D, Smith A, Brock MS, et al. Female genital schistosomiasis: case report and review of the literature. South Med J. 2004;97(5):525–7.
O’Brien DP, Leder K, Matchett E, et al. Illness in returned travelers and immigrants/refugees: the 6-year experience of two Australian infectious disease units. J Trav Med. 2006;13:145–52.
Spicher VM, Genin B, Jordan AR, et al. Peritoneal schistosomiasis: an unusual laparoscopic finding. J Pediatr Surg. 2004;39(4):631–3.
Ranque S, Chippaux J, Garcia A, Boussinesq M. Follow-up of
infections in children living in a community treated with ivermectin at 3-monthly intervals. Ann Trop Med Parasitol. 2001;95(4):389–93.
Marti H, Haji HJ, Savioli L, et al. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of
and other soil-transmitted helminth infections in children. Am J Trop Med Hyg. 1996;55(5):477–81.
Muennig P, Pallin D, Challah C, Khan K. The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloides in immigrants to the United States. Epidemiol Infect. 2004;132(6):1055–63.
Stauffer WM, Sellman JS, Walker PF. Biliary liver flukes (Opisthorciasis and Clonorhiasis) in immigrants in the United States: often subtle and diagnosed years after arrival. J Trav Med. 2004;11(3):157–60.
O’Neal SE, Townes JM, Wilkins PP, et al. Seroprevalence of antibodies against
cysticerci among refugees resettled in United States. Emerg Infect Dis. 2012;18(3):431–8.
World Health Organization. Preventive chemotherapy in human helminthiasis. Coordinated use of antihelminthic drugs in control interventions: a manual for health professionals and programme managers. WHO Press, World Health Organization, Geneva, Switzerland. Available at:
. Last accessed, July 10, 2012.
© Springer Science+Business Media New York (outside the USA) 2013